01.05.2013
- Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said...
30.04.2013
- Zoetis, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer, posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in...
12.04.2013
- Drugmaker Eli Lilly plans to lay off about 1,000 domestic sales representatives, or 30% of its U.S. sales force, as it faces new generic competition for its top drugs, a person...
29.03.2013
- The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and...
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
14.02.2013
- President Barack Obama's decision to spotlight drug rebates as a way to save money on Medicare is likely to be opposed by the pharmaceutical industry, which could potentially lose...
07.02.2013
- Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...
01.02.2013
- Pfizer's animal health subsidiary Zoetis raised $2.2 billion in its public offering on Thursday, becoming the largest IPO from a U.S. company since Facebook. Madison, New Jersey...
